ArticleScientific reports2025
Molecular epidemiology, distribution, and determinants of cutaneous leishmaniasis in Northeast Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- From dogma to data: charting a path forward for clinico-immunological research in Ethiopian cutaneous leishmaniasis.Infectious diseases of poverty · 2026Review
- Molecular diagnostics for cutaneous leishmaniasis: progress towards fulfilling the WHO target product profile.Parasitology · 2025Review
- Genetic variation of cutaneous leishmaniasis causative species in Ethiopia.Scientific reports · 2025Article
- Knowledge, attitude and preventive practice of cutaneous leishmaniasis in Sodo district, Ethiopia.Scientific reports · 2025Article
- Phlebotomine sand fly vector distribution, seasonality, blood meal sources, and infection rates in cutaneous leishmaniasis endemic areas of Northeast Ethiopia.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous leishmaniasis (CL) is a common vector-borne neglected tropical disease caused by protozoan parasites endemic to Ethiopia. Evidence of the molecular epidemiology of CL in communities in endemic areas of Ethiopia is scarce. This study aimed to investigate the molecular epidemiology, distribution, and determinants of CL. This community-based, cross-sectional study was conducted between March 2022 and 2023 on 356 suspected CL cases. DNA was extracted from the skin-scraped samples, and Leishmania parasite detection and species identification were performed via polymerase chain reaction (PCR). Variable and multivariate binary logistic regressions with AORs and p values ≤ 0.05 were used to identify determinants and determine the strength of the associations. Among the 384 suspected cases, 356 were included in the study, resulting in a response rate of 92.7%. Among the 356 suspected cases, 253 (71.1%) were positive for the Leishmania parasite according to PCR. Leishmania aethiopica was the only causative agent of CL in this study area. More confirmed CL cases were recorded among those living in poor housing conditions. The presence of animals in the house (AOR: 2.06; 95% CI: 1.23-3.43), being in the age group of < 9 years (AOR: 2.94; 95% CI: 1.21-7.14), being in the age group between 9 and 19 years (AOR: 3.23; 95% CI: 1.89-5.51), and the size of the household of five years and above (AOR: 2.78; 95% CI: 1.60-4.84) had a statistically significant association with CL. This study revealed that CL is a major public health problem in Northeast Ethiopia, and targeted and tailored control strategies are needed to mitigate the burden in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.